Qualified participants may receive:
- Research study medication (at no cost) which may treat multiple system atrophy and may slow disease progression
- Care and monitoring from a local study doctor at no cost
- Reimbursement for patient and caregiver travel expenses
Patients may continue on stable doses of some medications used to treat multiple system atrophy symptoms.